Showing 105 of 105on this page. Filters & sort apply to loaded results; URL updates for sharing.105 of 105 on this page
中国药科大学附属南京天印山医院RNK08954治疗KRAS G12D突变胰腺导管腺癌项目临床试验正式启动
KRAS G12D突变胰腺癌新药临床试验：口服靶向新药RNK08954-印塔健康官网
KRAS G12D新药临床：RNK08954 - 知乎
杭州RNK08954片I期临床试验-RNK08954片治疗KRAS G12D 突变型晚期实体瘤患者的I期临床研究-试药员招聘与临床试验信息平台
Drug Hunter - Articles Archives
KRASG12D（ON）抑制剂RMC-9805结构与临床前数据公开_财富号_东方财富网
KRAS G12D（ON）抑制剂RMC-9805结构与临床前数据公开医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
24AACR丨KRAS G12D抑制剂最新研究，汇总靶点进展 - 知乎
Discovery of RMC-9805, an Oral, RAS(ON)KRAS G12D-Selective C... - 雪球
Discovery and Characterization of RP03707: A Highly Potent and ...
Targeting KRAS G12D Mutations: Advances in Small Molecule Inhibitors ...
New exploration of KRASG12D inhibitors and the mechanisms of resistance ...
Zoldonrasib (RMC-9805) | KRAS G12D Inhibitor | CAS 2922732-54-3 ...
Identification of New KRAS G12D Inhibitors through Computer-Aided Drug ...
Discovery of Novel Noncovalent KRAS G12D Inhibitors through Structure ...
Calderasib (MK-1084) | KRAS G12C Inhibitor | MedChemExpress
RMC-9805 | Zoldonrasib | KRAS G12D Inhibitor | TargetMol
Frontiers | Discovery of potent and noncovalent KRASG12D inhibitors ...
研究发现KRAS G12D抑制剂_生物科技_健康一线资讯
Bi 1823911 Kras G12c Inhibitor Clinical Trial
RMC-9805 Triggers Tumor Regressions in KRAS G12D–Mutant Pancreatic ...
RMC-9805 | Zoldonrasib | KRAS G12D抑制剂 | 胰腺癌治疗剂 | TargetMol
CIMB | Free Full-Text | Identification of Dietary Bioflavonoids as ...
KRAS G12D inhibitor 14 | Ras | TargetMol
AbMole小讲堂丨RMC-9805：新型KRAS G12D抑制剂的机理与科研应用 - 知乎
2D structures of KRAS G12D inhibitors. 2D structures of KRAS G12D ...
KRAS G12D inhibitor 1 | | TargetMol
Figure 8 from Identification of New KRAS G12D Inhibitors through ...
RCSB PDB - 8AFB: CRYSTAL STRUCTURE OF KRAS-G12C IN COMPLEX WITH ...
Structure-Based Design and Synthesis of Potent and Selective KRAS G12D ...
Oncogenic KRAS G12C: Kinetic and redox characterization of covalent ...
Novel KRAS-G12C inhibitor of Novartis, modeling and comparison with ...
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRASG12C ...
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor: Cell
KRAS G12D inhibitor 19 | KRAS G12D inhibitor | MedChemExpress
2765254-39-3 化合物 KRAS G12D INHIBITOR 14 cas号2765254-39-3分子式、结构式、MSDS、熔点、沸点
RMC-9805 | 2922732-54-3 | AbMole | KRAS G12D inhibitor 18; Zoldonrasib
Discovery of Selective and Potent KRASG12D Inhibitors as Potential ...
The KRAS G12D-targeting XNAzyme retains catalytic activity inside RKO ...
Non-Small Cell Lung Cancer KRAS G12D Mutant Organoids - 北京科途医学科技有限公司 ...
(A) Sos-or EDTA-mediated nucleotide exchange of KRas(G12R) and ...
RCSB PDB - 8TXH: Crystal structure of KRAS G12D in complex with GDP and ...
Merck's MK-1084 KRAS G12C Inhibitor Shows Antitumor Activity in Phase 1 ...
RCSB PDB - 8R7W: Kras G12D in complex with compound 3
化合物 KRAS G12D INHIBITOR 14 CAS#: 2765254-39-3
RCSB PDB - 9E5F: Discovery of an Orally Bioavailable KRAS G12D Inhibitor
MK-1084 | 已进入III期临床的KRAS G12C靶向抑制剂（CAS# 2641216-67-1） - 知乎
WO2023278600A1 - Small molecule inhibitors of kras g12d mutant - Google ...
Small Molecule Inhibitors of KRAS G12C Mutant https://lnkd.in/gbRRE4eK ...
Dr Parham Cancer Academy on LinkedIn: KRAS(G12D) can be targeted by ...
RMC-9805 Hits Milestone in Early-Phase Clinical Trial of KRAS G12D ...
Figure 4 from Identification of New KRAS G12D Inhibitors through ...
Merck Announces MK-1084, an Investigational KRAS G12C Inhibitor, Shows ...
KRasG12C inhibitors in clinical trials: a short historical perspective ...
MK-1084 (Merck's macrocyclic KRAS G12C inhibitor) seems to be just one ...
Dual Inhibition of KRAS G12C and G12D Mutants as a Potential Treatment ...
